文献速递妇科

手术方式对早期高危中间型子宫内膜癌阴道近距离放疗后复发风险的影响

Effect of surgical approach on risk of recurrence after vaginal brachytherapy in early-stage high-intermediate risk endometrial cancer.
PubMed 文献 · Gynecol Oncol · 2020-12-23

这项回顾性队列研究纳入494例接受辅助阴道近距离放疗的早期高危中间型子宫内膜癌患者,其中363例接受微创手术。

要点

  • 总体复发率13.2%,开腹组10.7%与微创组14.0%无显著差异(p=0.58)。

核心结论

  • 早期高危中间型子宫内膜癌患者接受微创子宫切除术后辅助阴道近距离放疗,与开腹手术相比复发时间更短、复发风险更高。
  • 研究提示需进一步评估微创手术在高危中间型患者中的安全性。

研究设计与样本

  • 回顾性队列研究,纳入2005至2017年间接受阴道近距离放疗的早期高危中间型子宫内膜癌患者494例。
  • 其中363例接受微创子宫切除术,其余接受开腹子宫切除术。

主要发现

  • 开腹手术患者BMI更高(p=0.007),淋巴结取样率更低(p<0.001),淋巴血管间隙浸润率更低(p=0.036)。
  • 总体65例(13.2%)复发,开腹组14例(10.7%),微创组51例(14.0%),组间差异无统计学意义(p=0.58)。
  • 阴道复发在开腹组为4.6%,微创组为6.1%。
  • 与开腹组相比,微创组任何复发时间更短(p=0.022),盆腔复发时间更短(p=0.05),局部区域复发时间更短(p=0.021),任何原因死亡时间更短(p=0.039)。

临床怎么用

  • 对早期高危中间型子宫内膜癌患者选择微创手术时,应充分告知其可能更高的复发风险。
  • 术后辅助阴道近距离放疗后仍需关注局部区域复发,尤其是微创手术患者。

局限性

  • 本研究为回顾性队列研究,存在选择偏倚可能。
  • 开腹与微创组在BMI、淋巴结取样率和淋巴血管间隙浸润率等基线特征上存在差异。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: The objective was to determine if surgical approach affects time to recurrence in early-stage high-intermediate risk endometrial cancer (HIR-EC) treated with adjuvant vaginal brachytherapy (VBT). METHODS: In this retrospective cohort study, HIR-EC patients treated with VBT between 2005 and 2017 were identified and those who received open or minimally invasive hysterectomies (MIS) were included. Clinical and surgical variables were analyzed and time to recurrence was compared between surgical groups. RESULTS: We identified 494 patients, of which 363 had MIS hysterectomies, 92.5% had endometrioid histology, 45.7% were stage IA and 48.0% stage IB. Open hysterectomy patients had higher BMIs (p = 0.007), lower rates of lymph node sampling (p < 0.001) and lymphovascular space invasion (LVSI) (p = 0.036), however in patients who recurred, no differences were noted between groups. Overall, 65 patients (13.2%) recurred, 14 in the open group (10.7%) and 51 in the MIS group (14.0%) (p = 0.58), while vaginal recurrences were noted in 4.6% and 6.1% respectively. When compared to the open group, the MIS group had a significantly shorter time to any recurrence (p = 0.022), to pelvic (p = 0.05) and locoregional recurrence (p = 0.021) and to death from any cause (p = 0.039). After adjusting for age, BMI, grade, LVSI and surgery date, the MIS group had a higher risk of any recurrence (HR 2.29 (1.07-4.92), p = 0.034) and locoregional recurrence (HR 4.18 (1.44-12.1), p = 0.008). CONCLUSIONS: Patients with HIR-EC treated with VBT after MIS hysterectomy have a shorter time to recurrence and higher risk of recurrence when compared to open hysterectomy patients. Further studies into the safety of MIS in high-intermediate risk patients are required.

来源:Gynecol Oncol,查看原文。版权归原作者所有。

引用

  1. Philp L, Tannenbaum S, Haber H, et al. Effect of surgical approach on risk of recurrence after vaginal brachytherapy in early-stage high-intermediate risk endometrial cancer. Gynecol Oncol. 2020. PMID: 33358198. doi:10.1016/j.ygyno.2020.12.003

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。